Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
Francis Christian1, Andrew Thierman2, Erin Shirley2
11 University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Journal of Investigative Medicine High Impact Case Reports
|April 24, 2019
Summary
Cystic fibrosis-related diabetes (CFRD) in adults may improve with ivacaftor. This treatment showed sustained glycemic control and enhanced insulin secretion in a long-standing CFRD case.
Area of Science:
- Endocrinology
- Pulmonology
- Pharmacology
Background:
- Cystic fibrosis-related diabetes (CFRD) is a common complication in cystic fibrosis patients with pancreatic insufficiency.
- Current CFRD management relies on exogenous insulin due to impaired endogenous insulin secretion.
- Ivacaftor has shown potential in improving insulin secretion in pediatric CFRD patients.
Observation:
- A case study involving an adult patient with established CFRD.
Findings:
- Initiation of ivacaftor therapy led to a sustained improvement in the patient's glycemic control.
- This observation suggests ivacaftor may positively impact endogenous insulin secretion in adult CFRD patients.
Implications:
- Ivacaftor therapy might offer a novel therapeutic approach for managing CFRD in adults.
- Further research is warranted to explore the long-term effects and broader applicability of ivacaftor in adult CFRD management.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
746
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
746
01:24Cystic Fibrosis: Management
489
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
489
01:43Sustainable Development
14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
01:26Design Example: Sustainability in Concrete Building
394
As the construction industry moves towards more eco-friendly practices, concrete's adaptability and its ability to incorporate sustainable features make it a key material in the drive towards greener building solutions.
There are multiple approaches to achieve sustainability in a commercial concrete building. For instance, construct a concrete parking area under the building, utilizing pervious concrete paver blocks in open areas to facilitate rainwater collection through an underground...
There are multiple approaches to achieve sustainability in a commercial concrete building. For instance, construct a concrete parking area under the building, utilizing pervious concrete paver blocks in open areas to facilitate rainwater collection through an underground...
394
01:20Pathophysiology of Diabetes
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.3K
01:15Diabetes: Management and Pharmacotherapy
887
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
887